| mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0053 |
0.9 |
| mRNA |
bendamustine |
CTRPv2 |
pan-cancer |
AAC |
0.0058 |
0.9 |
| mRNA |
IPR-456 |
CTRPv2 |
pan-cancer |
AAC |
0.0055 |
0.9 |
| mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0052 |
0.9 |
| mRNA |
Bicalutamide |
GDSC1000 |
pan-cancer |
AAC |
-0.0049 |
0.9 |
| mRNA |
oligomycin a |
CTRPv2 |
pan-cancer |
AAC |
0.0051 |
0.9 |
| mRNA |
Sunitinib |
CTRPv2 |
pan-cancer |
AAC |
-0.005 |
0.9 |
| mRNA |
Crizotinib |
GDSC1000 |
pan-cancer |
AAC |
-0.0076 |
0.9 |
| mRNA |
AKT inhibitor VIII |
GDSC1000 |
pan-cancer |
AAC |
-0.0049 |
0.9 |
| mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0081 |
0.9 |